Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04832113
Other study ID # ET20-0284 ETADAPT
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 21, 2021
Est. completion date April 2025

Study information

Verified date August 2023
Source Centre Leon Berard
Contact Séverine METZGER
Phone +33478782786
Email severine.metzger@lyon.unicancer.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to evaluate the impact of Patient's Therapeutic Education (PTE) in Adapted Physical Activity (APA) ans dietetic on the reduction of interventions number on rectal volume (laxative or probe). The secondary objectives are to evaluate the contribution of Patient's Therapeutic Education (PTE) between the 2 arms on repositionnind during the radiotherapy session, the gastrointestinal toxicity, the need to use laxative or transit regulating treatment or techniques, the quality of life, the undernutrition and food intake, the evolution in eating/hydratation and physical habits. For the experimetal arm, the satisfaction and the compliance with PTE program will be evaluated, as well as the need of additionnal use of dietary and APA consultations.


Description:

Prostate cancer is the 3rd cause of cancer mortality in patient aged over 50 years. Radiotherapy treatment plans require specific conditions: - Reproductibility of patient's positioning (requiring management of bladder and rectal fillings at each session). - An image-guided treatment consisting in acquiring an image before each session. This pre-treatment Imaging allows the optimal adjustment of the target volume and organs at risk (bladder and rectum). To allow reproductibility of target volume positioning at each radiotherapy session, it's recommended to have an empty rectum at the time of the radiotherapy preparation scan, and to check repletion before each session. It's recommended that the patient has a comfortably full bladder to limit the volume of irradiated bladder mucosa. The radiotherapy teams don't have any recommendations concerning the rectum and manage this problem session by session, according to the repositioning Imaging of the current day. According to a pilot study carried out in 2017 in the radiotherapy department of the Léon Bérard center, an intervention for a dilated rectum (probe or laxative) was necessary for an average of 25% of session per patient. These rectal problems can be partly explained by the age (60-80 years) and sedentary lifestyle of patients with prostate cancer. Physical activities, adapted hydratation and changes in eating habits are an integral part of the constipation and flatulence prevention.


Recruitment information / eligibility

Status Recruiting
Enrollment 216
Est. completion date April 2025
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: I1: Age >= 18 years old. I2: Patient with prostatic adenocarcinoma with indication for first-line or post-operative radiotherapy (adjuvant or biologic recurrence). I3: Patient able to practice a physical activity (certificate of aptitude for adapted physical activity). I4: Life expectancy greater than 6 months. I5: Absence of chronic inflammatory intestinal disease or intestinal surgery. I6: Signed informed consent. I7: Patient covered by a medical insurance. I8. At least 20 sessions of radiotherapy planned Exclusion Criteria: E1: Patient does not understand and cannot read French. E2: Patient followed for a psychiatric pathology or presenting cognitive disorders. E3: Inability to comply with study follow-up goegraphical, social or psychological reasons. E4: Patient requiring tutorship or curatorship or patient deprived of liberty. E5: Participation to another clinical trial which may interfere with principal Endpoint assessment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Adapted Physical Activity and Dietetic
session in addtion conventional management dietetic, hydratation and physical activity
conventional management
Dietary and hydratation advices according to the recommendations

Locations

Country Name City State
France Groupe Hospitalier Mutualiste de Grenoble Institut Daniel HOLLARD Grenoble
France Centre Hospitalier Lyon Sud Pierre-Bénite
France Centre Eugène Marquis Rennes
France Chu de saint etienne Saint-Étienne Rhône-Alpes Auvergne
France Institut de Cancérologie de l'Ouest René Gauducheau Saint-Herblain

Sponsors (1)

Lead Sponsor Collaborator
Centre Leon Berard

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the impact of Patient's Therapeutic Education in APA on the reduction of interventions number on rectum Number of uninstallation during the radiotherapy session An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on patient's repositionning efficiency Rate of patients never uninstalled compared to patients uninstalled during prostate's radiotherapy An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the gastrointestinal toxicity Acute gastrointestinal toxicity = grade 2 (NCI- CTCAE V5) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the use of laxative or transit regulating treatment or techniques Prescribed laxatives or transit regulation treatments or techniques An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on patients' quality of life Using European Organisation for Research and Treatment of Cancer - Core Quality of life questionnaire (QLQC30) (Evaluation of patient's quality of life during the last 7 days - From 4 [worse reply] to 1 [better reply]) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the undernutrition Collection of patients' weight (kg) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the food intake Collection of patients' weight (kg) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the undernutrition Using Socio Economic Factor Index scale (SEFI) (Scale from 10 [I ate my entire meal] to 0 [I did not eat anything]) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the food intake Using Socio Economic Factor Index scale (SEFI) (Scale from 10 [I ate my entire meal] to 0 [I did not eat anything]) An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the undernutrition Using the "Eating and hydration habits questionnaire" An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the food intake Using the "Eating and hydration habits questionnaire" An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the evolution in eating habits Using the "Eating and hydration habits questionnaire" An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the evolution in hydratation habits Using the "Eating and hydration habits questionnaire" An average of 4 months
Secondary Evaluate the contribution of Patient's Therapeutic Education on the evolution in APA habits Using International Physical Activity Questionnaire (IPAQ) (Description of the physical activity during the last 7 days) An average of 4 months
Secondary Evaluate patient's satisfaction with Patient's Therapeutic Education program (experimental arm) Using satisfaction questionnaire (scale from 1 [worse evaluation] to 4 [better evaluation]) An average of 4 months
Secondary Evaluate the compliance to APA session recommendations Daily collection of steps numbers An average of 4 months
Secondary Evaluate the compliance to APA session recommendations Evaluation during phone calls every 15 days An average of 4 months
Secondary Evaluate the number of patients requiring additional dietetic session Evaluation during phone calls every 15 days An average of 4 months
Secondary Evaluate the number of patients requiring additional APA session Evaluation during phone calls every 15 days An average of 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Active, not recruiting NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A